A plain-language guide

osteogenesis imperfecta

What's known, what's still uncertain, and what's actively debated, written plainly, and built only from published medical research.

Growing map · 28 sourced statements Every statement names its source Updated 2026-08-04
Please read this first. This guide is a companion to your medical team, not a replacement, and it is not medical advice. Everything here is tied to published research. If something you expected is not here, it almost always means we have not mapped a source for it yet, not that it is unknown to medicine. osteogenesis imperfecta is an early, growing map, so it will look incomplete on purpose: we would rather show less and have every line be something you can check than fill the page with claims we cannot stand behind. For anything about your own situation, your clinicians hold the full picture. How this guide is built and why.

What's osteogenesis imperfecta?

Osteogenesis imperfecta, also called brittle bone disease, is an inherited disorder in which the bones break easily, often from little or no force. It is usually caused by changes in the genes that build type I collagen, the main structural protein of bone. Severity ranges enormously, from a mild tendency to fracture to severe forms with many fractures and bone deformity.

Also indexed asOMIM:166200, MONDO:0008146
Features mapped15
Treatments mapped3
Published sources11
Last reviewed2026-08-04

Signs and symptoms

Blue sclerae

A blue or grey tint to the whites of the eyes (blue sclerae) is a classic sign in many people with osteogenesis imperfecta, caused by the thin collagen letting the dark layer beneath show through. It is harmless in itself but a useful diagnostic clue.

Limited evidenceSource: PMID:40047057
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:41206390, OMIM:166220
Notesplain_language confirmed from PMID:41206390 via curation 2026-06-13. | regrounded primary OMIM:166220 -> PMID:40047057 on 2026-06-26 [Carrie Schluter, BCPA]
Last reviewed2026-06-26

Femoral bowing

In osteogenesis imperfecta the long bones of the legs can curve or bow. The bone is soft and repeated fractures heal unevenly, so deformities of the limbs are common, more so in the more severe forms of the condition.

Limited evidenceCurated reference: OMIM:166200
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:40047057
Notesplain_language confirmed from PMID:40047057 via curation 2026-06-25 [claude-draft].
Last reviewed2026-06-25

Dentinogenesis imperfecta

Because teeth also contain collagen, some people have dentinogenesis imperfecta: teeth that are discoloured, weak, and prone to chipping or wear. Dental review and protective care help preserve them.

Limited evidenceSource: PMID:40047057
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:41206390, OMIM:166220
Notesplain_language confirmed from PMID:41206390 via curation 2026-06-13. | regrounded primary OMIM:166220 -> PMID:40047057 on 2026-06-26 [Carrie Schluter, BCPA]
Last reviewed2026-06-26

Growth abnormality

Short stature is one of the most common features of osteogenesis imperfecta, alongside fractures and bony deformities. The soft, easily fractured bone and the deformities that follow can limit normal growth.

Limited evidenceSource: PMID:41424307
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:40650436, OMIM:166200
Notesplain_language confirmed from PMID:40650436 via curation 2026-06-25 [claude-draft]. | regrounded primary OMIM:166200 -> PMID:41424307 on 2026-06-26 [Carrie Schluter, BCPA]
Last reviewed2026-06-26

Autosomal dominant inheritance

Osteogenesis imperfecta is most often caused by changes in the COL1A1 or COL1A2 genes, which carry the instructions for type I collagen, the main protein scaffold of bone. These changes interfere with collagen and leave the bone fragile.

Limited evidenceSource: PMID:40650436
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:42011197, OMIM:166220
Notesplain_language confirmed from PMID:42011197 via curation 2026-06-25 [claude-draft]. | regrounded primary OMIM:166220 -> PMID:40650436 on 2026-06-26 [Carrie Schluter, BCPA]
Last reviewed2026-06-26

Hearing impairment

Hearing loss is common and tends to develop in adolescence or adulthood, because the tiny bones of the middle ear are also affected. Regular hearing checks let it be picked up and managed early.

Limited evidenceSource: PMID:41638701
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:41611235, OMIM:166220
Notesplain_language confirmed from PMID:41611235 via curation 2026-06-13. | regrounded primary OMIM:166220 -> PMID:41638701 on 2026-06-26 [Carrie Schluter, BCPA]
Last reviewed2026-06-26

Wormian bones

On a skull X-ray, people with osteogenesis imperfecta often have extra small islands of bone within the joints of the skull, called Wormian bones. They are a helpful diagnostic clue and reflect the abnormal way bone forms in the condition.

Limited evidenceSource: PMID:40047057
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesOMIM:166220
Notesplain_language confirmed from PMID:40047057 via curation 2026-06-18 [carrie (curation)]. | regrounded primary OMIM:166220 -> PMID:40047057 on 2026-06-26 [Carrie Schluter, BCPA]
Last reviewed2026-06-26

Joint hypermobility

Because osteogenesis imperfecta affects collagen, the same protein that gives ligaments their strength, the joints are often unusually loose and flexible. This joint hypermobility can contribute to instability, pain, and a tendency to sprains.

Limited evidenceCurated reference: OMIM:166200
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:42157492
Notesplain_language confirmed from PMID:42157492 via curation 2026-06-18 [carrie (curation)].
Last reviewed2026-06-18

Increased susceptibility to fractures

Osteogenesis imperfecta makes bone fragile, so fractures happen easily and tend to recur, often after little or no force. This bone fragility and the resulting recurrent fractures are the central feature of the condition, and the breaks can lead to lasting bone deformity.

Limited evidenceSource: PMID:41401950
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesOMIM:166220
Notesplain_language confirmed from PMID:41401950 via curation 2026-06-25 [claude-draft]. | regrounded primary OMIM:166220 -> PMID:41401950 on 2026-06-26 [Carrie Schluter, BCPA]
Last reviewed2026-06-26

Recurrent fractures

Repeated bone fractures, often from minor bumps or even normal handling in babies, are the central feature. Fracture frequency commonly eases after puberty in milder forms. Prompt orthopaedic care and rehabilitation help protect function and mobility.

Limited evidenceSource: PMID:41401950
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:41611235, OMIM:166220
Notesplain_language confirmed from PMID:41611235 via curation 2026-06-13. | regrounded primary OMIM:166220 -> PMID:41401950 on 2026-06-26 [Carrie Schluter, BCPA]
Last reviewed2026-06-26

Short stature

Many people with osteogenesis imperfecta are shorter than expected for their family. Repeated fractures, curvature of the spine, and the underlying weakness of the collagen that builds bone all limit growth, and short stature is one of the most common features of the more involved types.

Limited evidenceSource: PMID:40650436
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:40219777, OMIM:166220
Notesplain_language confirmed from PMID:40219777 via curation 2026-06-18 [carrie (curation)]. | regrounded primary OMIM:166220 -> PMID:40650436 on 2026-06-26 [Carrie Schluter, BCPA]
Last reviewed2026-06-26

Kyphosis

Curvature of the spine, including kyphosis (a forward rounding of the upper back), can develop in osteogenesis imperfecta because the vertebrae are soft and can compress or fracture. Spinal deformities are watched over time and may need bracing or surgery in more severe cases.

Limited evidenceCurated reference: OMIM:166220
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:42011197
Notesplain_language confirmed from PMID:42011197 via curation 2026-06-25 [claude-draft].
Last reviewed2026-06-25

Scoliosis

Curvature of the spine (scoliosis) is common in osteogenesis imperfecta because the vertebrae are soft and can compress or fracture. In more severe cases the curve can progress enough to affect breathing and may need bracing or surgery.

Limited evidenceSource: PMID:41854906
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:41954840, OMIM:166220
Notesplain_language confirmed from PMID:41954840 via curation 2026-06-18 [carrie (curation)]. | regrounded primary OMIM:166220 -> PMID:41854906 on 2026-06-26 [Carrie Schluter, BCPA]
Last reviewed2026-06-26

Reduced bone mineral density

Bones carry less mineral than normal (low bone mass), which is part of why they are fragile. Bone density is monitored over time and informs decisions about bone-strengthening treatment.

Limited evidenceCurated reference: OMIM:166220
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:41465594
Notesplain_language confirmed from PMID:41465594 via curation 2026-06-13.
Last reviewed2026-06-13

Bowing of limbs due to multiple fractures

In osteogenesis imperfecta the long bones of the arms and legs can curve or bow, both because the bone itself is soft and because repeated fractures heal unevenly. Bowing of the long bones is a visible sign of the bone fragility at the heart of the condition.

Limited evidenceCurated reference: OMIM:166220
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:40219777
Notesplain_language confirmed from PMID:40219777 via curation 2026-06-18 [carrie (curation)].
Last reviewed2026-06-18

How it is diagnosed

Osteogenesis imperfecta, type I

Diagnosed using: COL1A1/COL1A2 genetic testing.

Limited evidenceSource: PMID:41401950
The source text this rests on
“…diagnosis has evolved from traditional imaging-based assessment to comprehensive evaluation guided by genotype-phenotype…”
An excerpt quoted verbatim from the source named above, shown as recorded. The full sentence is in the linked source.
Evidence ratingweak
Confidence (0-1)0.7
Replicationunreplicated
Notesconfirmed from PMID:41401950 via curation 2026-06-25
Last reviewed2026-06-25

Treatment and management

What the research describes, not a recommendation. Treatment decisions belong with your clinician.

This covers treatments that appear in the published research mapped here. Investigational and experimental therapies are not included, so their absence is a boundary of this map, not a sign they do not exist.

bisphosphonates

Bisphosphonates are the main medicines used in osteogenesis imperfecta. They strengthen bone by slowing the cells that break bone down, which can reduce fracture rate and bone pain, especially in moderate-to-severe disease. They do not change the underlying collagen problem, and the decision to use them rests with the specialist team. Physiotherapy, mobility support, and orthopaedic care remain central.

Used to help with: Osteogenesis imperfecta, type I.

Limited evidenceSource: PMID:40698241
The source text this rests on
“Bisphosphonates play a key role in managing OI.”
An excerpt quoted verbatim from the source named above, shown as recorded. The full sentence is in the linked source.
Evidence ratingweak
Confidence (0-1)0.7
Replicationunreplicated
Notesconfirmed from PMID:40698241 via curation 2026-06-13
Last reviewed2026-06-13

bisphosphonates

Bisphosphonates are the main medicine used in osteogenesis imperfecta. They are the primary drug treatment and can reduce how often fractures happen while increasing bone mineral density. They do not fix the underlying collagen problem, and the decision to use them rests with the specialist team.

Used to help with: Osteogenesis imperfecta, type I.

Limited evidenceSource: PMID:42011197
The source text this rests on
“Bisphosphonates continue to be the primary pharmacologic treatment, effectively reducing fracture risk, and increasing bone mineral…”
An excerpt quoted verbatim from the source named above, shown as recorded. The full sentence is in the linked source.
Evidence ratingweak
Confidence (0-1)0.7
Replicationunreplicated
Notesconfirmed from PMID:42011197 via curation 2026-06-25
Last reviewed2026-06-25

supportive care (physical therapy and orthotic support)

Alongside medicine, supportive care is central in osteogenesis imperfecta. Good nutrition, vitamin D, personalized physical therapy, and orthotic support help maintain function and reduce fractures, and there is no cure for the underlying condition.

Used to help with: Osteogenesis imperfecta, type I.

Limited evidenceSource: PMID:42011197
The source text this rests on
“…good nutrition, vitamin D supplementation, personalized physical therapy, and orthotic support, remains essential for improving function and preventing…”
An excerpt quoted verbatim from the source named above, shown as recorded. The full sentence is in the linked source.
Evidence ratingweak
Confidence (0-1)0.7
Replicationunreplicated
Notesconfirmed from PMID:42011197 via curation 2026-06-25
Last reviewed2026-06-25

What changes how it shows up

Carrying the genetic change is not the whole story. The factors below are described in the research mapped here as changing whether, or how strongly, the condition appears. They modulate how the genotype is expressed; they do not, on their own, cause or cure it.

Sillence type (I-IV)

Osteogenesis imperfecta is sorted into clinical types that describe how severe it is. In a large group of adults, type I (the mildest, most common form) made up about three-quarters of people, with the moderate type IV and the more severe type III making up most of the rest. The type a person has helps describe the likely course of the condition.

Described as modulating: Osteogenesis imperfecta, type I.

Limited evidenceSource: PMID:41206390
The source text this rests on
“266 (76.2%) had type I OI, 55 (15.8%) had type IV, and 19 (5.4%) had type…”
An excerpt quoted verbatim from the source named above, shown as recorded. The full sentence is in the linked source.
Evidence ratingweak
Confidence (0-1)0.7
Replicationunreplicated
Notesconfirmed from PMID:41206390 via curation 2026-06-25
Last reviewed2026-06-25

How to read the evidence labels

Widely acceptedSpecialists broadly agree on this.
Strong evidenceBacked by solid, repeated research.
Moderate evidenceReasonable evidence, still being confirmed.
Limited evidenceSome evidence, but not yet convincing.
Early evidenceAn early finding that needs more study.
Experts disagreeResearchers actively disagree about this.
No longer supportedLater, stronger evidence or guidance overturned this.

Where this comes from

This guide is built from 11 published source(s). Every claim above links back to one of them. Click any source ID to read the original on PubMed.

OMIM:166200 · Orphanet/HPO annotations for Osteogenesis imperfecta, type I
OMIM:166220 · Orphanet/HPO annotations for Osteogenesis imperfecta, type IV
PMID:40047057 · COL1A1 and COL1A2 Gene Variants Causing Osteogenesis Imperfecta in a Major Referral Center of India.
PMID:40650436 · Molecular and Clinical Landscape of Osteogenesis Imperfecta: Unraveling Autosomal Recessive Forms, Therapeutic Outcomes, and Bone Mineral Density in Carriers.
PMID:40698241 · A Systematic Review on the Efficacy of Bisphosphonates on Osteogenesis Imperfecta.
PMID:41206390 · Baseline Characteristics of the TOPaZ Study: Randomised Trial of Teriparatide and Zoledronic Acid Compared with Standard
PMID:41401950 · [Comprehensive considerations for the diagnosis, treatment, and management of osteogenesis imperfecta].
PMID:41424307 · A Novel Biallelic Variant in The SERPINH1 Gene in Two Siblings Diagnosed with Osteogenesis Imperfecta Type X: Evidence of Intrafamilial Clinical Variability.
PMID:41638701 · Atypical femoral fractures in a Mexican cohort of children and adolescents with osteogenesis imperfecta. Analysis of trajectories.
PMID:41854906 · Posterior spinal fusion with pedicle screw-based constructs in osteogenesis imperfecta: a systematic review of surgical and radiographic outcomes.
PMID:42011197 · What's New in Osteogenesis Imperfecta.

Take it further

Printed, source-linked documents built from this condition's graph — ready to bring to an appointment or attach to a coverage request. Every claim carries its published source, the same as this guide.